Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | UQCRB | P14927 | 2/20 | 0.42 |
| ▸ | IKBKB | O14920 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.42 |
| ▸ | GHSR | Q92847 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30372693 | 1.00 | MAPT (0.50) | MAPTMEN1KMT2AHIF1AHDAC1 | |
| SCHEMBL26488673 | 0.91 | MAPT (0.59) | MAPTMEN1KMT2AHIF1AHDAC1 | |
| SCHEMBL26488662 | 0.89 | KMT2A (0.48) | MAPTMEN1KMT2AHDAC1ALDH1A1 | |
| SCHEMBL30373016 | 0.89 | KMT2A (0.48) | MAPTMEN1KMT2AHDAC1ALDH1A1 | |
| SCHEMBL23883383 | 0.86 | HDAC1 (0.53) | MAPTMEN1KMT2AHDAC1ALDH1A1 | |
| SCHEMBL22718808 | 0.86 | HDAC1 (0.53) | MAPTMEN1KMT2AHDAC1ALDH1A1 | |
| SCHEMBL22718732 | 0.85 | HDAC1 (0.52) | MAPTMEN1KMT2AHDAC1ALDH1A1 | |
| SCHEMBL30372215 | 0.84 | MAPT (0.48) | MAPTMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL26488691 | 0.84 | MAPT (0.48) | MAPTMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL23898763 | 0.83 | ESR1 (0.37) | MAPTALDH1A1LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230131501-A1 | THERAPEUTIC USES OF INHIBITORS OF THE RNA-BINDING PROTEIN HuR | UNIVERSITY OF KANSAS | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230131501-A1 | THERAPEUTIC USES OF INHIBITORS OF THE RNA-BINDING PROTEIN HuR | HNRNPH1, ELAVL1, RBM3 | MAPT 2784/4885MEN1 2590/4885KMT2A 2237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.